Category: Cardiovascular

Predictive Role of Biomarkers in COVID-19 Mortality

Posted on | Posted on John Murphy | Leave a Comment on Predictive Role of Biomarkers in COVID-19 Mortality

Ayşe Yılmaz,1 Öztürk Taşkın,1 Ufuk Demir,1 and Veysel G Soylu2 Cureus. 2023 Jan; 15(1): e34173. Published online 2023 Jan 24 doi: 10.7759/cureus.34173 PMCID: PMC9950690PMID: 36843833 Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has resulted in high mortality among patients in critical intensive care units. Hence, identifying mortality markers in the follow-up and treatment of these patients is essential. This study aimed to evaluate […]

Weight-loss drug can reverse heart failure symptoms, study finds

Posted on | Posted on John Murphy | Leave a Comment on Weight-loss drug can reverse heart failure symptoms, study finds

Semaglutide injections trigger ‘very large improvements’ in patients with hearts too stiff to fill properly. Andrew Gregory  Amsterdam 25 Aug 2023 05.55 EDT Weight-loss jabs can reverse the symptoms of heart failure, according to a global trial that experts say could revolutionise treatment. Heart failure is one of the world’s fastest growing health threats. About […]

Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Posted on | Posted on John Murphy | Leave a Comment on Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently, the drug has been shown to potentially reduce the risk of cardiovascular events in those with coronary artery disease.2 Colchicine has several potential mechanisms of action, […]

Heart-disease risk soars after COVID — even with a mild case

Posted on | Posted on John Murphy | Leave a Comment on Heart-disease risk soars after COVID — even with a mild case

Authors: Saima May Sidik 10 February 2022 Massive study shows a long-term, substantial rise in risk of cardiovascular disease, including heart attack and stroke, after a SARS-CoV-2 infection. Even a mild case of COVID-19 can increase a person’s risk of cardiovascular problems for at least a year after diagnosis, a new study1 shows. Researchers found that […]

Former Senior FDA Official: Manufacturers, FDA Negligent In Not Investigating Covid-19 Vaccine Risks To Heart Health

Posted on | Posted on John Murphy | Leave a Comment on Former Senior FDA Official: Manufacturers, FDA Negligent In Not Investigating Covid-19 Vaccine Risks To Heart Health

Authors: DAVID GORTLER FEBRUARY 10, 2022 Manufacturers, FDA, and CDC must investigate serious cardiovascular incidents related to the Pfizer and Moderna Covid vaccines. From day ,one the U.S. Food and Drug Administration knew the Covid-19 vaccine was linked to serious heart trouble in recipients. The FDA medical officer review of Pfizer’s original Covid-19 application notes “clinically important […]

Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae

Posted on | Posted on John Murphy | Leave a Comment on Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae

Authors: Yapeng Su 28, Dan Yuan 28, Daniel G. Chen 28,Mark M. Davis, Jason D. Goldman, James R. Heath 29 Highlights Longitudinal multiomics associate PASC with autoantibodies, viremia and comorbidities Reactivation of latent viruses during initial infection may contribute to PASC Subclinical autoantibodies negatively correlate with anti-SARS-CoV-2 antibodies Gastrointestinal PASC uniquely present with post-acute expansion of cytotoxic T cells […]

Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs

Posted on | Posted on John Murphy | Leave a Comment on Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs

Authors: Taejoon Won, Megan K. Wood, David M. Hughes, Monica V. Talor, Zexu Ma Jowaly Schneider, et al. Published:January 12, 2022DOI:https://doi.org/10.1016/j.ebiom.2022.103812 Background Thromboembolism is a life-threatening manifestation of coronavirus disease 2019 (COVID-19). We investigated a dysfunctional phenotype of vascular endothelial cells in the lungs during COVID-19. Methods We obtained the lung specimens from the patients […]

13 ways that the SARS-CoV-2 spike protein causes damage

Posted on | Posted on John Murphy | Leave a Comment on 13 ways that the SARS-CoV-2 spike protein causes damage

Authors: Posted on January 13, 2022 by Jesse Santiano, M.D. The SARS-CoV-2 virus has four structural proteins. The spike, membrane, envelop, and nucleocapsid proteins. The spike protein protrudes from the middle of the coronavirus and attaches to the ACE2 receptor of cells to start the process of cell entry, replication, and infection. The two major parts of the […]

Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning

Posted on | Posted on John Murphy | Leave a Comment on Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning

Authors: Steven R Gundry Originally published 8 Nov 2021Circulation. 2021;144:A10712 Abstract Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is based […]

Study Finds Teenage Boys Six Times More Likely To Suffer Heart Problems From Vaccine Than Be Hospitalized by COVID

Posted on | Posted on John Murphy | Leave a Comment on Study Finds Teenage Boys Six Times More Likely To Suffer Heart Problems From Vaccine Than Be Hospitalized by COVID

Authors; Paul Joseph Watson via Summit News, Research conducted by the University of California has found that teenage boys are six times more likely to suffer from heart problems caused by the COVID-19 vaccine than to be hospitalized as a result of COVID-19 itself. “A team led by Dr Tracy Hoeg at the University of California […]